Each year, approximately 432,000 women die from heart disease. Women, however, only make up 25% of the participant pool in clinical trials based around heart research. The “Bloomer Bra” seeks to reshape the way research data is collected in cardiology.
How can practitioners hope to integrate, fund, and evaluate the constantly-evolving healthcare landscape into clinical practices? The ACC has an answer. Following the association’s first annual Healthcare Innovation Statement in 2016, members created the 2017 Roadmap for Innovation in November. The statement identifies three primary fields of focus: Digital Health, Big Data, and Precision Health.
The startup Qrativ is the joint venture of the biotech company nference and Mayo Clinic. While nference supplies AI technology to the startup, Mayo Clinic offers the clinical expertise needed to give new purpose to pre-existing drugs.
The AHN “Design the Chip Challenge” to offer $10,000 prize for best design of a portable, secure technology allowing immediate access to patients’ medical histories.
Last Thursday, the Boston Scientific Connected Patient Challenge II concluded with a live even at Google’s headquarters in Kendall Square. The focus of this year’s challenge was Big Data, and participants were encouraged to submit ideas on how to improve patient outcomes, increase efficiency in delivering care, and drive down the cost of care using data analytics.
Boston Scientific Announces Six Finalists in 2nd Annual Connected Patient Challenge, Focused on Healthcare Data Analytics »
Finalists will present their ideas to a panel of judges and a live audience in Cambridge on March 9; Top winners will be awarded up to $50,000 of in-kind support to advance submitted concept
With less than 24 hours until the submission deadline, the Boston Scientific Big Data Challenge has received over 40 submissions. Participants have submitted a variety of ideas that use Big Data to address everything from the opioid epidemic to drug reimbursement.
Cambridge-based Foundation Medicine, a molecular information company that sells genomic profiling tests for solid tumors and hematologic malignancies, is leading a new data exchange partner program, the Precision Medicine Exchange Consortium (PMEC) to facilitate the exchange of molecular information and research and improve cancer care.